The evaluation of miR-9-5p expression in primary breast cancer might help the identification of breast cancer molecular subgroups characterized by different clinical behaviour and represent a target for novel therapeutic interventions aimed to re-induce hormone receptor expression in ER negative breast cancers. Here, NR4A1 is linked to breast cancer.